Chemistry:Tribendimidine

From HandWiki
Short description: Chemical compound
Tribendimidine
Tribendimidine.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC28H32N6
Molar mass452.606 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Tribendimidine is a broad-spectrum anthelmintic agent developed in China , at the National Institute of Parasitic Diseases in Shanghai. It is a derivative of amidantel.[1]

In clinical trials, it was highly effective in treating ankylostomiasis, ascariasis and enterobiasis.[2] It is also effective against clonorchiasis.[3] However, animal studies suggest it is ineffective in treating Schistosoma mansoni or Fasciola hepatica disease.[1] The drug has also performed well in trials against opisthorchiasis, curing about 70% of cases.[4]

Tribendimidine is manufactured by Shandong Xinhua Pharmaceutical Company Limited in Zibo, Shandong, China . It was approved by the China Food and Drug Administration in 2007.[citation needed]

References

  1. 1.0 1.1 "Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini". Antimicrobial Agents and Chemotherapy 51 (3): 1096–1098. March 2007. doi:10.1128/AAC.01366-06. PMID 17194822.  Free full text.
  2. "Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China". Acta Tropica 94 (1): 1–14. April 2005. doi:10.1016/j.actatropica.2005.01.013. PMID 15777691. 
  3. "Development and application of anthelminthic drugs in China". Acta Tropica 200: 105181. December 2019. doi:10.1016/j.actatropica.2019.105181. PMID 31542370. 
  4. "New drug shows promise against Asian liver fluke". Reuters. 2010-11-24. https://www.reuters.com/article/us-liver-fluke-drugs-idUSTRE6AO00520101125.